# Laboratory Value Tables

This section provides reference ranges and underwriting guidelines for common laboratory tests used in life insurance risk assessment. These tables should be used in conjunction with the applicant's complete medical history and other underwriting evidence.

## General Principles for Laboratory Interpretation

1. **Clinical Context**: Interpret lab values within the context of the applicant's overall health profile
2. **Trending**: Multiple results over time are more valuable than isolated findings
3. **Age/Gender Adjustments**: Apply appropriate reference ranges based on demographic factors
4. **Confirmation**: Abnormal findings may require confirmation through additional testing
5. **Fasting Status**: Consider whether appropriate fasting protocols were followed
6. **Medication Effects**: Account for medications that may affect laboratory values
7. **Laboratory Variation**: Consider differences in methodologies between laboratories

## Lipid Profile

### Total Cholesterol

| Value (mg/dL) | Classification | Underwriting Action |
|---------------|----------------|---------------------|
| <160 | Optimal | Preferred Plus eligible |
| 160-199 | Desirable | Preferred eligible |
| 200-239 | Borderline High | Standard Plus eligible; evaluate other risk factors |
| 240-279 | High | Standard; +0 to +50 debits |
| 280-349 | Very High | +50 to +100 debits |
| ≥350 | Extremely High | Table 2-4; consider APS |

**Modifying Factors**:
- HDL >60 mg/dL: -25 debits
- Multiple readings showing improvement: -25 debits
- Statin therapy with good compliance: -25 debits
- Family history of premature CAD: +25 debits
- Multiple cardiac risk factors: +25 debits

### LDL Cholesterol

| Value (mg/dL) | Classification | Underwriting Action |
|---------------|----------------|---------------------|
| <100 | Optimal | Preferred Plus eligible |
| 100-129 | Near Optimal | Preferred eligible |
| 130-159 | Borderline High | Standard Plus eligible |
| 160-189 | High | Standard; +0 to +50 debits |
| 190-219 | Very High | +50 to +100 debits |
| ≥220 | Extremely High | Table 2-4; consider APS |

**Modifying Factors**:
- Statin therapy with documented reduction: -25 debits
- Diabetes or established CAD: +25 debits
- Genetic hyperlipidemia: Individual consideration

### HDL Cholesterol

| Value (mg/dL) | Classification | Underwriting Action |
|---------------|----------------|---------------------|
| <30 | Very Low | +75 to +100 debits |
| 30-39 | Low | +25 to +50 debits |
| 40-49 | Borderline Low | Standard eligible |
| 50-59 | Normal | Standard Plus eligible |
| ≥60 | High (Protective) | Preferred/Preferred Plus eligible |

**Modifying Factors**:
- Regular exercise with low HDL: -25 debits
- Metabolic syndrome with low HDL: +25 debits
- Gender adjustment: Women typically have higher HDL levels

### Triglycerides

| Value (mg/dL) | Classification | Underwriting Action |
|---------------|----------------|---------------------|
| <150 | Normal | Preferred Plus eligible |
| 150-199 | Borderline High | Preferred eligible |
| 200-499 | High | Standard; +0 to +75 debits based on level |
| 500-999 | Very High | Table 2-4; consider APS |
| ≥1000 | Extremely High | Table 4+; require APS |

**Modifying Factors**:
- Non-fasting sample: Less weight on elevated values
- Diabetes with elevated triglycerides: +25 debits
- Alcohol use with elevated triglycerides: +25 debits
- Medication therapy with good control: -25 debits

### Total Cholesterol/HDL Ratio

| Ratio | Classification | Underwriting Action |
|-------|----------------|---------------------|
| <3.5 | Optimal | Preferred Plus eligible |
| 3.5-4.4 | Desirable | Preferred eligible |
| 4.5-5.9 | Borderline | Standard Plus eligible |
| 6.0-7.9 | High Risk | Standard; +25 to +75 debits |
| ≥8.0 | Very High Risk | Table 2+; consider APS |

## Glucose Metabolism

### Fasting Blood Glucose

| Value (mg/dL) | Classification | Underwriting Action |
|---------------|----------------|---------------------|
| <100 | Normal | Preferred Plus eligible |
| 100-125 | Impaired Fasting Glucose | Standard Plus to Standard; +0 to +50 debits |
| 126-139 | Diabetes Range (single reading) | Standard to Table 2; require follow-up |
| 140-199 | Elevated | Table 2-4; require APS |
| ≥200 | Significantly Elevated | Table 4+; require APS |

**Modifying Factors**:
- Non-fasting sample: Less weight on mildly elevated values
- A1C confirmation: Essential for values >125 mg/dL
- Family history of diabetes: +25 debits for borderline values
- Obesity with elevated glucose: +25 debits
- Stable values over time: -25 debits

### Hemoglobin A1C

| Value (%) | Classification | Underwriting Action |
|-----------|----------------|---------------------|
| <5.7 | Normal | Preferred Plus eligible |
| 5.7-6.0 | High Normal | Preferred to Standard Plus |
| 6.1-6.4 | Prediabetes | Standard; +0 to +50 debits |
| 6.5-6.9 | Diabetes - Good Control | Table 2-3 |
| 7.0-7.9 | Diabetes - Fair Control | Table 3-5 |
| 8.0-8.9 | Diabetes - Poor Control | Table 5-7 |
| 9.0-9.9 | Diabetes - Very Poor Control | Table 7-9 |
| ≥10.0 | Diabetes - Extremely Poor Control | Table 9+; consider decline |

**Modifying Factors**:
- Duration of diabetes: +25 debits per 5 years
- Presence of complications: +25 to +100 debits
- Improving trend: -25 debits
- Worsening trend: +25 debits
- Age >60 with mild elevation: -25 debits

## Kidney Function

### Creatinine

| Value (mg/dL) | Gender | Classification | Underwriting Action |
|---------------|--------|----------------|---------------------|
| <0.6 | Either | Low | Standard; consider muscle wasting |
| 0.6-1.2 | Male | Normal | Preferred Plus eligible |
| 0.5-1.1 | Female | Normal | Preferred Plus eligible |
| 1.3-1.5 | Male | Mildly Elevated | Standard; +0 to +50 debits |
| 1.2-1.4 | Female | Mildly Elevated | Standard; +0 to +50 debits |
| 1.6-1.9 | Male | Moderately Elevated | Table 2-4; require APS |
| 1.5-1.8 | Female | Moderately Elevated | Table 2-4; require APS |
| 2.0-2.9 | Either | Severely Elevated | Table 4-8; require APS |
| ≥3.0 | Either | Very Severely Elevated | Table 8+; consider decline |

**Modifying Factors**:
- Age >70: Allow slightly higher creatinine
- Muscular build: Allow slightly higher creatinine
- Stable values over time: -25 debits
- Rising trend: +25 to +50 debits
- Proteinuria with elevated creatinine: +50 debits

### Estimated Glomerular Filtration Rate (eGFR)

| Value (mL/min/1.73m²) | Classification | Underwriting Action |
|----------------------|----------------|---------------------|
| ≥90 | Normal | Preferred Plus eligible |
| 60-89 | Mildly Decreased | Preferred to Standard Plus |
| 45-59 | Mildly to Moderately Decreased | Standard to Table 2 |
| 30-44 | Moderately to Severely Decreased | Table 3-6; require APS |
| 15-29 | Severely Decreased | Table 6+; consider decline |
| <15 | Kidney Failure | Decline |

**Modifying Factors**:
- Age >70 with mild reduction: Less debits
- Stable values over time: -25 debits
- Declining trend: +25 to +50 debits
- Proteinuria with reduced eGFR: +50 debits
- Diabetes with reduced eGFR: +50 debits
- Hypertension with reduced eGFR: +25 debits

### Urinalysis - Protein

| Finding | Classification | Underwriting Action |
|---------|----------------|---------------------|
| Negative | Normal | Preferred Plus eligible |
| Trace | Minimal | Preferred eligible |
| 1+ | Mild | Standard Plus to Standard |
| 2+ | Moderate | Standard to Table 2; consider APS |
| 3+ | Severe | Table 3-6; require APS |
| 4+ | Very Severe | Table 6+; require APS |

**Modifying Factors**:
- Transient causes (exercise, fever): Less debits
- Persistent proteinuria: +25 to +50 debits
- Diabetes with proteinuria: +50 debits
- Hypertension with proteinuria: +25 debits
- Quantitative confirmation recommended for 2+ or greater

### Urine Albumin-to-Creatinine Ratio (UACR)

| Value (mg/g) | Classification | Underwriting Action |
|--------------|----------------|---------------------|
| <30 | Normal | Preferred Plus eligible |
| 30-299 | Microalbuminuria | Standard to Table 2 |
| 300-999 | Clinical Albuminuria | Table 3-6; require APS |
| ≥1000 | Severe Albuminuria | Table 6+; consider decline |

## Liver Function

### Alanine Aminotransferase (ALT)

| Value (U/L) | Gender | Classification | Underwriting Action |
|-------------|--------|----------------|---------------------|
| <40 | Male | Normal | Preferred Plus eligible |
| <31 | Female | Normal | Preferred Plus eligible |
| 40-55 | Male | Borderline | Preferred to Standard Plus |
| 31-45 | Female | Borderline | Preferred to Standard Plus |
| 56-70 | Male | Mildly Elevated | Standard; +0 to +25 debits |
| 46-60 | Female | Mildly Elevated | Standard; +0 to +25 debits |
| 71-100 | Male | Moderately Elevated | Standard to Table 2; consider APS |
| 61-90 | Female | Moderately Elevated | Standard to Table 2; consider APS |
| 101-200 | Either | Severely Elevated | Table 2-4; require APS |
| >200 | Either | Very Severely Elevated | Table 4+; require APS |

**Modifying Factors**:
- Isolated elevation with normal AST/GGT: -25 debits
- Obesity with mild elevation: -25 debits
- Alcohol use with elevation: +25 debits
- Medication effect (statins, etc.): -25 debits
- Hepatitis history with elevation: +50 debits
- Multiple elevated liver enzymes: +50 debits

### Aspartate Aminotransferase (AST)

| Value (U/L) | Gender | Classification | Underwriting Action |
|-------------|--------|----------------|---------------------|
| <35 | Male | Normal | Preferred Plus eligible |
| <31 | Female | Normal | Preferred Plus eligible |
| 35-50 | Male | Borderline | Preferred to Standard Plus |
| 31-45 | Female | Borderline | Preferred to Standard Plus |
| 51-70 | Male | Mildly Elevated | Standard; +0 to +25 debits |
| 46-60 | Female | Mildly Elevated | Standard; +0 to +25 debits |
| 71-100 | Male | Moderately Elevated | Standard to Table 2; consider APS |
| 61-90 | Female | Moderately Elevated | Standard to Table 2; consider APS |
| 101-200 | Either | Severely Elevated | Table 2-4; require APS |
| >200 | Either | Very Severely Elevated | Table 4+; require APS |

**Modifying Factors**: Same as ALT

### Gamma-Glutamyl Transferase (GGT)

| Value (U/L) | Classification | Underwriting Action |
|-------------|----------------|---------------------|
| <50 | Normal | Preferred Plus eligible |
| 50-100 | Mildly Elevated | Standard Plus to Standard |
| 101-200 | Moderately Elevated | Standard to Table 2; consider APS |
| 201-500 | Severely Elevated | Table 2-4; require APS |
| >500 | Very Severely Elevated | Table 4+; require APS |

**Modifying Factors**:
- Alcohol use with elevation: +50 debits
- Medication effect: -25 debits
- Isolated GGT elevation: -25 debits
- Multiple elevated liver enzymes: +50 debits
- Obesity with elevation: -25 debits

### Alkaline Phosphatase (ALP)

| Value (U/L) | Classification | Underwriting Action |
|-------------|----------------|---------------------|
| <120 | Normal | Preferred Plus eligible |
| 120-150 | Borderline | Preferred to Standard Plus |
| 151-200 | Mildly Elevated | Standard; +0 to +25 debits |
| 201-300 | Moderately Elevated | Standard to Table 2; consider APS |
| 301-500 | Severely Elevated | Table 2-4; require APS |
| >500 | Very Severely Elevated | Table 4+; require APS |

**Modifying Factors**:
- Isolated elevation with normal other LFTs: -25 debits
- Bone disease with elevation: -25 debits
- Pregnancy with elevation: -25 debits
- Multiple elevated liver enzymes: +50 debits

## Cardiac Biomarkers

### High-Sensitivity C-Reactive Protein (hs-CRP)

| Value (mg/L) | Classification | Underwriting Action |
|--------------|----------------|---------------------|
| <1.0 | Low Risk | Preferred Plus eligible |
| 1.0-3.0 | Average Risk | Preferred to Standard Plus |
| 3.1-10.0 | High Risk | Standard; +0 to +50 debits |
| >10.0 | Very High Risk or Non-cardiac | Table 2+; require APS |

**Modifying Factors**:
- Recent infection/inflammation: Less weight on elevated values
- Multiple cardiac risk factors with elevation: +25 debits
- Statin therapy with elevation: +25 debits
- Trending downward: -25 debits

### NT-proBNP

| Value (pg/mL) | Age <75 | Age ≥75 | Underwriting Action |
|---------------|---------|---------|---------------------|
| <125 | Normal | Normal | Preferred Plus eligible |
| 125-300 | Borderline | Normal | Preferred to Standard Plus |
| 301-450 | Elevated | Borderline | Standard; +0 to +50 debits |
| 451-900 | Moderately Elevated | Elevated | Table 2-4; require APS |
| 901-1800 | Severely Elevated | Moderately Elevated | Table 4-6; require APS |
| >1800 | Very Severely Elevated | Severely Elevated | Table 6+; consider decline |

**Modifying Factors**:
- Renal dysfunction: Less weight on mildly elevated values
- Known heart failure: Rate for heart failure
- Age >80: Less weight on mildly elevated values
- Multiple cardiac risk factors: +25 debits

### BNP

| Value (pg/mL) | Classification | Underwriting Action |
|---------------|----------------|---------------------|
| <50 | Normal | Preferred Plus eligible |
| 50-99 | Borderline | Preferred to Standard Plus |
| 100-200 | Elevated | Standard; +0 to +50 debits |
| 201-400 | Moderately Elevated | Table 2-4; require APS |
| 401-900 | Severely Elevated | Table 4-6; require APS |
| >900 | Very Severely Elevated | Table 6+; consider decline |

**Modifying Factors**: Similar to NT-proBNP

## Cancer Markers

### Prostate-Specific Antigen (PSA)

| Age | Value (ng/mL) | Classification | Underwriting Action |
|-----|--------------|----------------|---------------------|
| <50 | <2.0 | Normal | Preferred Plus eligible |
| <50 | 2.0-2.5 | Borderline | Preferred eligible |
| <50 | 2.6-4.0 | Elevated | Standard Plus; require follow-up |
| <50 | 4.1-10.0 | Significantly Elevated | Standard to Table 2; require APS |
| <50 | >10.0 | Very Significantly Elevated | Table 4+; require APS |
| 50-59 | <3.0 | Normal | Preferred Plus eligible |
| 50-59 | 3.0-3.5 | Borderline | Preferred eligible |
| 50-59 | 3.6-4.0 | Elevated | Standard Plus; require follow-up |
| 50-59 | 4.1-10.0 | Significantly Elevated | Standard to Table 2; require APS |
| 50-59 | >10.0 | Very Significantly Elevated | Table 4+; require APS |
| 60-69 | <4.0 | Normal | Preferred Plus eligible |
| 60-69 | 4.0-5.0 | Borderline | Preferred eligible |
| 60-69 | 5.1-10.0 | Elevated | Standard Plus to Standard; require follow-up |
| 60-69 | 10.1-20.0 | Significantly Elevated | Table 2-4; require APS |
| 60-69 | >20.0 | Very Significantly Elevated | Table 6+; require APS |
| ≥70 | <5.0 | Normal | Preferred Plus eligible |
| ≥70 | 5.0-7.0 | Borderline | Preferred eligible |
| ≥70 | 7.1-10.0 | Elevated | Standard Plus to Standard; require follow-up |
| ≥70 | 10.1-20.0 | Significantly Elevated | Table 2-4; require APS |
| ≥70 | >20.0 | Very Significantly Elevated | Table 6+; require APS |

**Modifying Factors**:
- PSA velocity >0.75 ng/mL/year: +50 debits
- Free PSA <10%: +50 debits
- Free PSA >25%: -25 debits
- History of prostatitis: -25 debits
- Recent prostate manipulation: Less weight on elevated values
- 5-alpha reductase inhibitor use: Double PSA value

### Carcinoembryonic Antigen (CEA)

| Value (ng/mL) | Smoking Status | Classification | Underwriting Action |
|---------------|----------------|----------------|---------------------|
| <3.0 | Non-smoker | Normal | Preferred Plus eligible |
| 3.0-5.0 | Non-smoker | Borderline | Standard Plus to Standard; consider follow-up |
| >5.0 | Non-smoker | Elevated | Table 2+; require APS |
| <5.0 | Smoker | Normal | Based on smoking status |
| 5.0-10.0 | Smoker | Borderline | Standard; consider follow-up |
| >10.0 | Smoker | Elevated | Table 2+; require APS |

**Modifying Factors**:
- History of colorectal cancer: Rate for cancer
- History of inflammatory bowel disease: -25 debits
- Other non-malignant GI conditions: -25 debits

## Substance Testing

### Cotinine

| Value | Classification | Underwriting Action |
|-------|----------------|---------------------|
| Negative | Non-tobacco user | Non-tobacco rates eligible |
| Positive | Tobacco user | Tobacco rates apply |

**Modifying Factors**:
- Nicotine replacement therapy: Individual consideration
- Secondhand smoke exposure: Individual consideration
- Marijuana use without tobacco: Individual consideration

### Carbohydrate-Deficient Transferrin (CDT)

| Value (%) | Classification | Underwriting Action |
|-----------|----------------|---------------------|
| <1.7 | Normal | No additional rating |
| 1.7-2.5 | Borderline | +0 to +50 debits; consider APS |
| 2.6-4.0 | Elevated | Table 2-4; require APS |
| >4.0 | Significantly Elevated | Table 4+; require APS |

**Modifying Factors**:
- Liver disease without alcohol use: Less weight on elevated values
- Admitted moderate alcohol use: -25 debits
- Elevated GGT with elevated CDT: +50 debits

## Complete Blood Count (CBC)

### Hemoglobin

| Gender | Value (g/dL) | Classification | Underwriting Action |
|--------|--------------|----------------|---------------------|
| Male | <13.0 | Low | Standard to Table 2; require APS |
| Male | 13.0-16.5 | Normal | Preferred Plus eligible |
| Male | 16.6-18.0 | Borderline High | Standard Plus to Standard |
| Male | >18.0 | High | Standard to Table 2; require APS |
| Female | <11.5 | Low | Standard to Table 2; require APS |
| Female | 11.5-15.5 | Normal | Preferred Plus eligible |
| Female | 15.6-17.0 | Borderline High | Standard Plus to Standard |
| Female | >17.0 | High | Standard to Table 2; require APS |

**Modifying Factors**:
- Mild anemia with known cause: -25 debits
- Chronic anemia: +25 to +50 debits
- Polycythemia: +50 to +100 debits
- Smoker with high hemoglobin: -25 debits
- High altitude residence: -25 debits for high values

### White Blood Cell Count (WBC)

| Value (x10³/μL) | Classification | Underwriting Action |
|-----------------|----------------|---------------------|
| <3.5 | Low | Standard to Table 2; consider APS |
| 3.5-10.5 | Normal | Preferred Plus eligible |
| 10.6-15.0 | Mildly Elevated | Standard Plus to Standard |
| 15.1-20.0 | Moderately Elevated | Standard to Table 2; consider APS |
| >20.0 | Significantly Elevated | Table 2+; require APS |

**Modifying Factors**:
- Recent infection: Less weight on elevated values
- Chronic inflammation: +25 debits
- Medication effect: -25 debits
- Persistent abnormality: +50 debits

### Platelet Count

| Value (x10³/μL) | Classification | Underwriting Action |
|-----------------|----------------|---------------------|
| <100 | Low | Standard to Table 2; require APS |
| 100-150 | Borderline Low | Standard Plus to Standard |
| 151-450 | Normal | Preferred Plus eligible |
| 451-600 | Borderline High | Standard Plus to Standard |
| >600 | High | Standard to Table 2; require APS |

**Modifying Factors**:
- Stable mild abnormality: -25 debits
- Medication effect: -25 debits
- Persistent significant abnormality: +50 debits
- Known hematologic disorder: Rate for the disorder
